Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01341288 · ClinicalTrials.gov registry record · Phase 1
Robotic Seed Implantation for Prostate Cancer Brachytherapy
A Phase 1 study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT01341288 is a Phase 1 study that was terminated before completion, run by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. The registered enrollment target is 2 participants.
The verdict
NCT01341288, a Phase 1 study, was terminated before completion, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
A robotic brachytherapy device will be used to assist physicians in performing seed implantation to the prostate. EUCLIDIAN is the first robotic system designed to allow automatic placement of radioactive seeds by robot and thus reduce operator dependence. The clinical study is designed to evaluate the dosimetric quality, accuracy and patient self-reported quality of life scores after robotic brachytherapy.
Interventions
- DEVICE EUCLIDIAN Robot
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2008-07-29 |
| Est. Completion | 2015-02-27 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01341288
The ClinicalTrials.gov registry entry for NCT01341288 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EUCLIDIAN Robot is the first listed.
NCT01341288 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01341288 about?
NCT01341288 is a clinical study titled "Robotic Seed Implantation for Prostate Cancer Brachytherapy". A robotic brachytherapy device will be used to assist physicians in performing seed implantation to the prostate. EUCLIDIAN is the first robotic system designed to allow automatic placement of radioactive seeds by robot and thus reduce operator dependence. The clinical study is designed to evaluate ...
What is the current status of trial NCT01341288?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2008-07-29. Estimated completion is 2015-02-27.
What interventions are being tested in trial NCT01341288?
The interventions under investigation include: EUCLIDIAN Robot (DEVICE).
Who is sponsoring clinical trial NCT01341288?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.